Skip to main content

Table 3 T and N downstaging (intention to treat population: 90 patients)

From: A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

 

Arm A

Arm B

pvalue

(BVZ + CAP + RT)

(CAP + RT)

(n° patients = 44)

(n° patients = 46)

Parameter

No. of patients

%

No. of patients

%

 

ypT

    

0.0429

 Better

26

59

18

39

 Equal

16

37

28

61

 Worse

1

2

0

0

 Missinga

1

2

0

0

ypN

    

0.0865

 Better

24

55

35

76

 Equal

15

34

8

18

 Worse

4

9

2

4

 No Evaluableb

0

0

1

2

 Missinga

1

2

0

0

ypT and ypN

    

0.5612

 Better in both

18

41

16

35

 Better in one of them

14

32

20

43

 Worse in both

11

25

9

20

 No Evaluableb

0

0

1

2

 Missinga

1

2

0

0

  1. aNo surgery.
  2. bIt was reported as ypNx.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us